Literature DB >> 19770055

Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.

Juergen Dukart1, Karsten Mueller, Annette Horstmann, Barbara Vogt, Stefan Frisch, Henryk Barthel, Georg Becker, Harald E Möller, Arno Villringer, Osama Sabri, Matthias L Schroeter.   

Abstract

FDG-PET ([18F]fluorodeoxyglucose positron emission tomography) is frequently used to improve the differential diagnosis of dementia. However, a fundamental methodological issue of the reference area for the intensity normalization procedure is still unsolved. Here, we systematically compared the two most commonly used normalization methods to the cerebral and to the cerebellar metabolic rate for glucose with regard to detection and differentiation of dementia syndromes. FDG-PET imaging was performed on 19 subjects with early Alzheimer's disease, 13 subjects with early frontotemporal lobar degeneration and 10 subjects complaining of memory impairment, which had not been confirmed by comprehensive clinical testing. Images were normalized to either the cerebral or the cerebellar metabolic rate for glucose. Differences in relative regional glucose metabolism were assessed by voxelwise comparison. Analysis using the two normalization procedures revealed remarkable differential effects. Whereas cerebellar normalization was superior in identifying dementia patients in comparison to control subjects, cerebral normalization showed better results for differential diagnosis between types of dementia. These effects were shown for both, Alzheimer's disease and frontotemporal lobar degeneration. Relative hypermetabolism in comparison to the control group was only detected in both kinds of dementia using global normalization. The results indicate that normalization has a decisive impact on diagnostic accuracy in dementia. While cerebellar normalization seems to be more sensitive for early diagnosis, cerebral global normalization might be superior for differential diagnostic purposes in dementia syndromes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19770055     DOI: 10.1016/j.neuroimage.2009.09.017

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  54 in total

1.  Visual and statistical analysis of ¹⁸F-FDG PET in primary progressive aphasia.

Authors:  Jordi A Matías-Guiu; María Nieves Cabrera-Martín; María Jesús Pérez-Castejón; Teresa Moreno-Ramos; Cristina Rodríguez-Rey; Rocío García-Ramos; Aida Ortega-Candil; Marta Fernandez-Matarrubia; Celia Oreja-Guevara; Jorge Matías-Guiu; José Luis Carreras
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-03       Impact factor: 9.236

2.  Comparison of PASL, PCASL, and background-suppressed 3D PCASL in mild cognitive impairment.

Authors:  Sudipto Dolui; Marta Vidorreta; Ze Wang; Ilya M Nasrallah; Abass Alavi; David A Wolk; John A Detre
Journal:  Hum Brain Mapp       Date:  2017-07-24       Impact factor: 5.038

3.  Healthy brain ageing assessed with 18F-FDG PET and age-dependent recovery factors after partial volume effect correction.

Authors:  Stijn Bonte; Pieter Vandemaele; Stijn Verleden; Kurt Audenaert; Karel Deblaere; Ingeborg Goethals; Roel Van Holen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-11-23       Impact factor: 9.236

4.  Validation of 18F-FDG-PET Single-Subject Optimized SPM Procedure with Different PET Scanners.

Authors:  Luca Presotto; Tommaso Ballarini; Silvia Paola Caminiti; Valentino Bettinardi; Luigi Gianolli; Daniela Perani
Journal:  Neuroinformatics       Date:  2017-04

5.  A pilot study in epilepsy patients using simultaneous PET/MR.

Authors:  Yu-Shin Ding; Bang-Bin Chen; Christopher Glielmi; Kent Friedman; Orrin Devinsky
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

6.  Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.

Authors:  Sepideh Shokouhi; Desmond Campbell; Aaron B Brill; Harry E Gwirtsman
Journal:  Brain Pathol       Date:  2016-09       Impact factor: 6.508

7.  18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.

Authors:  Silvia Morbelli; Matteo Bauckneht; Dario Arnaldi; Agnese Picco; Matteo Pardini; Andrea Brugnolo; Ambra Buschiazzo; Marco Pagani; Nicola Girtler; Alberto Nieri; Andrea Chincarini; Fabrizio De Carli; Gianmario Sambuceti; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-07       Impact factor: 9.236

8.  Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer's disease.

Authors:  Jens Göttler; Christine Preibisch; Isabelle Riederer; Lorenzo Pasquini; Panagiotis Alexopoulos; Karl Peter Bohn; Igor Yakushev; Ebba Beller; Stephan Kaczmarz; Claus Zimmer; Timo Grimmer; Alexander Drzezga; Christian Sorg
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-12       Impact factor: 6.200

9.  Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Authors:  Pilar M Ferraro; Charles Jester; Christopher A Olm; Katerina Placek; Federica Agosta; Lauren Elman; Leo McCluskey; David J Irwin; John A Detre; Massimo Filippi; Murray Grossman; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

10.  Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment.

Authors:  Eun Hyun Seo; I L Han Choo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.